Trials / Completed
CompletedNCT01460030
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is an intra-individual titration study of KRN1493 to evaluate the safety and efficacy of KRN1493 for the treatment of hypercalcemia in patients with parathyroid carcinoma or intractable primary hyperparathyroidism (PHPT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cinacalcet HCl | Oral administration |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2011-10-26
- Last updated
- 2017-03-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01460030. Inclusion in this directory is not an endorsement.